Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).
2000
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
30
Citations
NaN
KQI